Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine
Authors:
- 18 March 2011
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 28 (4) , 295-303
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and Tolerability of Cyclobenzaprine Extended Release for Acute Muscle Spasm: A Pooled AnalysisPostgraduate Medicine, 2010
- Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical designCurrent Medical Research and Opinion, 2009
- A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteersClinical Therapeutics, 2009
- Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young AdultsClinical Drug Investigation, 2008
- Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice GuidelineAnnals of Internal Medicine, 2007
- Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain SocietyAnnals of Internal Medicine, 2007
- Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxaloneClinical Therapeutics, 2004
- Patients with low back painPostgraduate Medicine, 1996
- Cyclobenzaprine in intractable pain syndromes with muscle spasmJAMA, 1978
- Cyclobenzaprine: A novel centrally acting skeletal muscle relaxantNeuropharmacology, 1975